Strata Critical Medical, Inc. (SRTA) Financial Statements
Strata Critical Medical, Inc. (SRTA) reported trailing twelve-month revenue of $256.0M (up 66.8% year on year) and net income of $40.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$49.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SRTAStrata Critical Medical, Inc.Follow SRTA — free
—
Price chart with a free account
- Market cap
- 412.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Sep 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 50.5 | 146.1 | 225.2 | 146.8 | 197.1 | 256.0 | |
| Gross profit | 10.5 | 22.3 | 42.1 | 29.6 | 41.1 | 54.4 | |
| Operating income | -24.1 | -53.5 | -68.1 | -22.5 | -22.4 | -20.4 | |
| Pre-tax income | -43.7 | -28.0 | -57.5 | -16.2 | -20.1 | -23.2 | |
| Income tax | -3.6 | -0.8 | -1.5 | 0.0 | 0.0 | 0.0 | |
| Net income | -40.1 | -27.3 | -56.1 | -27.3 | 41.3 | 40.2 | |
| Diluted EPS ($) | -0.93 | -0.38 | -0.76 | -0.35 | 0.50 | 0.49 | |
| Diluted shares (mn) | 42.9 | 71.2 | 73.5 | 77.5 | 82.1 | — |
USD millions · SEC XBRL
Strata Critical Medical, Inc. — questions
- What is Strata Critical Medical, Inc.'s revenue?
- $256.0M over the twelve months to 2026-06-30, up 66.8% year on year, from its 10-Q and 10-K filings.
- What is Strata Critical Medical, Inc.'s net income?
- $40.2M over the twelve months to 2026-06-30.
- What is Strata Critical Medical, Inc.'s free cash flow?
- -$49.5M over the twelve months to 2026-06-30.
- What are Strata Critical Medical, Inc.'s diluted earnings per share?
- $0.49 over the twelve months to 2026-06-30.
Every figure on this page comes from Strata Critical Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.